{
  "docId": "019de076-8cfe-74f8-8267-71bfaaa75a6b",
  "docSlug": "6f650cb16e144ff2cbcc39c10e5d03e1",
  "documentTitle": "23andMe | Investor Presentation Deck | 39 slides",
  "authorId": "23andme",
  "authorName": "23andMe",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 39,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The slide demonstrates how 23andMe's genetic data can rescue or refine clinical trial results by identifying biomarkers that stratify patient response.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-8cfe-74f8-8267-71bfaaa75a6b/11",
  "deckHref": "/decks/019de076-8cfe-74f8-8267-71bfaaa75a6b",
  "deckJsonHref": "/decks/019de076-8cfe-74f8-8267-71bfaaa75a6b.json",
  "deckAnchorHref": "/decks/019de076-8cfe-74f8-8267-71bfaaa75a6b#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.45,
        "x": 0.52,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Kaplan-Meier survival curve stratified by PRS (hypoT) score",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e1776e86-832a-49ff-94e9-f2f67f85b688",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.45,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Kaplan-Meier survival curve for Phase 3 trial (Atezolizumab + Nab-Paclitaxel vs Placebo)",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2953515-bd11-437d-928e-eee4daec7e83",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.12,
        "x": 0.52,
        "y": 0.18
      },
      "kind": "metric",
      "text": "N~150, HR~0.62",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c6278c5-ae24-40b6-999c-97792da880f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.12,
        "x": 0.35,
        "y": 0.18
      },
      "kind": "metric",
      "text": "N~900, HR~0.84",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa805f75-987a-4df9-8069-a939d48fd6a5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "Phase 3 trial failure -> Withdrawal of triple-negative breast cancer indication",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "397ebb11-cbbb-42ba-a055-18807dd33066",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "PMID: 30345906; PMID: 34099659",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9d75728a-084e-4a98-be6c-b9d816725354",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "POWER: Immune Genetics Implemented as an IO Clinical Biomarker",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "14b790e0-2217-4667-b8fa-f482d8f6b726",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Data Story Arc",
      "slug": "data-story-arc",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "b0d70e75-d446-4d37-9637-ea3d7e10d8e7",
      "evidence": "Kaplan-Meier survival curve for Phase 3 trial (Atezolizumab + Nab-Paclitaxel vs Placebo)",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "06500731-95ff-49ef-bf46-4066854da246",
      "evidence": "Contrasts a failed trial result with a successful biomarker-stratified result.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 39,
      "from": 9,
      "beatId": "93eec936-fceb-4bb2-ab9b-6265df978407",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 9-39 present 23andMe's solution, including their therapeutic pipeline and approach",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 3,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "240cc394-c2c1-42eb-aefc-c6cedba90fa6",
      "evidence": "Slides 3-12 present a logical chain of 23andMe's approach and its benefits",
      "position": 0,
      "objective": "Understand 23andMe's value proposition",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}